http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103992234-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-08
filingDate 2014-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103992234-B
titleOfInvention A kind of preparation method of tamoxifen citrate E isomers
abstract The invention provides a kind of preparation method of tamoxifen citrate E isomers, comprise the steps: 1) taking structural formula suc as formula the intermediate of preparing tamoxifen citrate shown in I as raw material, in the mixed solution of a certain proportion of water and organic solvent, under acid condition, carry out dehydration, obtain the mixture of structural formula intermediate 2 as shown in formula III suc as formula the intermediate 1 shown in II and structural formula; 2) in a certain amount of organic solvent, intermediate 1, intermediate 2 and citric acid or its hydrate reaction, cooling crystallization obtain structural formula suc as formula the Z-tamoxifen citrate shown in IV and structural formula the mixture suc as formula the E-tamoxifen citrate shown in V; 3) in a certain proportion of water and organic solvent, the mixture of Z-tamoxifen citrate and E-tamoxifen citrate is carried out to recrystallization twice. The present invention can prepare high-purity tamoxifen citrate E isomers, for Zhong Jian institute provides impurity reference substance, has solved the problem in actual production process, E-isomers being detected.
priorityDate 2014-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9902509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4536516-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421239439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23696331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415783739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22619319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411746874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25010734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448860624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451829787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448734522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909

Total number of triples: 47.